| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $781.4M | +97.0% |
| R&D Expense | $327.6M | -7.6% |
| SG&A Expense | $501.1M | +0.0% |
| Operating Income | -$165.0M | +68.1% |
| Pre-tax Income | -$196.7M | +62.6% |
| Income Tax | $1.2M | -45.5% |
| Net Income | -$197.9M | +62.6% |
| EPS (Basic) | -$1.60 | +64.0% |
| EPS (Diluted) | -$1.60 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $411.3M | +17.1% |
| Accounts Receivable | $264.9M | +28.3% |
| Inventory | $81.4M | -44.4% |
| Current Assets | $789.0M | +3.0% |
| Total Assets | $885.1M | +12.2% |
| Current Liabilities | $185.5M | -25.1% |
| Total Liabilities | $656.5M | +10.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.9M | +85.2% |
| Capital Expenditures | $403K | -47.9% |
| Investing Cash Flow | -$403K | +40.2% |
| Financing Cash Flow | $149.2M | -62.2% |
| Free Cash Flow | -$88.3M | +85.2% |
| +64.0% |
| Stockholders' Equity |
| $228.5M |
| +17.5% |